BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2498095)

  • 1. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.
    Odenholt I; Isaksson B; Nilsson L; Cars O
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):136-41. PubMed ID: 2498095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A
    Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
    Bustamante CI; Drusano GL; Tatem BA; Standiford HC
    Antimicrob Agents Chemother; 1984 Nov; 26(5):678-82. PubMed ID: 6440477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.
    McGrath BJ; Lamp KC; Rybak MJ
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1931-7. PubMed ID: 8239608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The postantibiotic effect of meropenem and imipenem on selected bacteria.
    Nadler HL; Pitkin DH; Sheikh W
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A
    Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.
    Majcherczyk PA; Kunz S; Hattenberger M; Vaxelaire J; Zak O; O'Reilly T
    J Antimicrob Chemother; 1994 Oct; 34(4):485-505. PubMed ID: 7646646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.
    Maggiolo F; Taras A; Frontespezi S; Legnani MC; Silanos MA; Pravettoni G; Suter F
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1416-8. PubMed ID: 8092847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin.
    McGrath BJ; Marchbanks CR; Gilbert D; Dudley MN
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1723-5. PubMed ID: 8215293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subpopulations of variants resistant to imipenem in Pseudomonas aeruginosa.
    Nilsson L; Nilsson M; Jendle J
    J Antimicrob Chemother; 1988 Nov; 22(5):643-9. PubMed ID: 3145266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Kentepozidis N; Antonopoulou A; Plachouras D; Tsaganos T; Giamarellou H
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):113-7. PubMed ID: 15698716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD; Wolter DJ; Wickman PA; Reisbig MD
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.
    Hessen MT; Pitsakis PG; Levison ME
    J Infect Dis; 1988 Sep; 158(3):542-8. PubMed ID: 3137272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of various technics in the determination of sensitivity of Pseudomonas aeruginosa to imipenem].
    Maugein J; Fourche J; Pellegrin JL; Mormède M
    Pathol Biol (Paris); 1990 May; 38(5):362-5. PubMed ID: 2114605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils.
    Sasahara T; Satoh Y; Sekiguchi T; Suzuki K; Irinoda K; Takayama Y; Sakamoto A; Kitasato H; Okamoto R; Inoue M
    J Infect Chemother; 2003 Dec; 9(4):297-303. PubMed ID: 14691649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.